362 related articles for article (PubMed ID: 29440387)
1. The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.
Kawakami Y; Kurihara Y; Saito Y; Fujita Y; Yamashita T; Takei K
J Neurosci; 2018 Mar; 38(10):2589-2604. PubMed ID: 29440387
[TBL] [Abstract][Full Text] [Related]
2. The soluble form of LOTUS inhibits Nogo receptor type 1-mediated signaling induced by B lymphocyte stimulator and chondroitin sulfate proteoglycans.
Kawakami Y; Saito Y; Nakagawa R; Kurihara Y; Takei K
Neurosci Lett; 2018 Sep; 683():61-68. PubMed ID: 29953923
[TBL] [Abstract][Full Text] [Related]
3. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand.
Kurihara Y; Iketani M; Ito H; Nishiyama K; Sakakibara Y; Goshima Y; Takei K
Mol Cell Neurosci; 2014 Jul; 61():211-8. PubMed ID: 25034269
[TBL] [Abstract][Full Text] [Related]
4. Nogo receptor antagonist LOTUS exerts suppression on axonal growth-inhibiting receptor PIR-B.
Kurihara Y; Takai T; Takei K
J Neurochem; 2020 Nov; 155(3):285-299. PubMed ID: 32201946
[TBL] [Abstract][Full Text] [Related]
5. The carboxyl-terminal region of Crtac1B/LOTUS acts as a functional domain in endogenous antagonism to Nogo receptor-1.
Kurihara Y; Arie Y; Iketani M; Ito H; Nishiyama K; Sato Y; Nakamura F; Mizuki N; Goshima Y; Takei K
Biochem Biophys Res Commun; 2012 Feb; 418(2):390-5. PubMed ID: 22281491
[TBL] [Abstract][Full Text] [Related]
6. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
[TBL] [Abstract][Full Text] [Related]
7. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
[TBL] [Abstract][Full Text] [Related]
8. LOTUS Inhibits Neuronal Apoptosis and Promotes Tract Regeneration in Contusive Spinal Cord Injury Model Mice.
Ito S; Nagoshi N; Tsuji O; Shibata S; Shinozaki M; Kawabata S; Kojima K; Yasutake K; Hirokawa T; Matsumoto M; Takei K; Nakamura M; Okano H
eNeuro; 2018; 5(5):. PubMed ID: 30560203
[TBL] [Abstract][Full Text] [Related]
9. Axonal branching in lateral olfactory tract is promoted by Nogo signaling.
Iketani M; Yokoyama T; Kurihara Y; Strittmatter SM; Goshima Y; Kawahara N; Takei K
Sci Rep; 2016 Dec; 6():39586. PubMed ID: 28000762
[TBL] [Abstract][Full Text] [Related]
10. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.
Chivatakarn O; Kaneko S; He Z; Tessier-Lavigne M; Giger RJ
J Neurosci; 2007 Jul; 27(27):7117-24. PubMed ID: 17611264
[TBL] [Abstract][Full Text] [Related]
11. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
Wang KC; Kim JA; Sivasankaran R; Segal R; He Z
Nature; 2002 Nov; 420(6911):74-8. PubMed ID: 12422217
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
[TBL] [Abstract][Full Text] [Related]
13. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Mi S; Lee X; Shao Z; Thill G; Ji B; Relton J; Levesque M; Allaire N; Perrin S; Sands B; Crowell T; Cate RL; McCoy JM; Pepinsky RB
Nat Neurosci; 2004 Mar; 7(3):221-8. PubMed ID: 14966521
[TBL] [Abstract][Full Text] [Related]
14. Blockade of chondroitin sulfate proteoglycans-induced axonal growth inhibition by LOTUS.
Kurihara Y; Saito Y; Takei K
Neuroscience; 2017 Jul; 356():265-274. PubMed ID: 28571719
[TBL] [Abstract][Full Text] [Related]
15. Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation.
Sato Y; Iketani M; Kurihara Y; Yamaguchi M; Yamashita N; Nakamura F; Arie Y; Kawasaki T; Hirata T; Abe T; Kiyonari H; Strittmatter SM; Goshima Y; Takei K
Science; 2011 Aug; 333(6043):769-73. PubMed ID: 21817055
[TBL] [Abstract][Full Text] [Related]
16. Axonal regeneration and functional recovery driven by endogenous Nogo receptor antagonist LOTUS in a rat model of unilateral pyramidotomy.
Ueno R; Takase H; Suenaga J; Kishimoto M; Kurihara Y; Takei K; Kawahara N; Yamamoto T
Exp Neurol; 2020 Jan; 323():113068. PubMed ID: 31629859
[TBL] [Abstract][Full Text] [Related]
17. Cyclic-AMP induces Nogo-A receptor NgR1 internalization and inhibits Nogo-A-mediated collapse of growth cone.
Gopalakrishna R; Mades A; Oh A; Zhu A; Nguyen J; Lin C; Kindy MS; Mack WJ
Biochem Biophys Res Commun; 2020 Mar; 523(3):678-684. PubMed ID: 31948754
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the p75 receptor signal attenuates the effect of ephrin-B3 and promotes axonal regeneration of the injured optic nerve.
Uesugi N; Kimura Y; Yamashita T
Cell Death Dis; 2013 Mar; 4(3):e557. PubMed ID: 23519126
[TBL] [Abstract][Full Text] [Related]
19. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein.
Wong ST; Henley JR; Kanning KC; Huang KH; Bothwell M; Poo MM
Nat Neurosci; 2002 Dec; 5(12):1302-8. PubMed ID: 12426574
[TBL] [Abstract][Full Text] [Related]
20. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI.
Yamashita T; Tohyama M
Nat Neurosci; 2003 May; 6(5):461-7. PubMed ID: 12692556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]